ERBB2 and cancer: Previously reported focal CNAs in MSS primary cancers included single-copy and double-copy gains involving CCND1, ERBB2, MYC and KLF5, and deletions of ARID1A, SMAD4 and APC7,31 (Supplementary Table 17).